Clinical trial of Covaxin's 3rd dose to start soon, Dr Sanjay Roy explains the need

A clinical trial of Covaxin's 3rd dose will start soon in Delhi AIIMS. Principal Investigator Dr Sanjay Roy explained the need for the process in conversation with ABP News. 

Bharat Biotech on Thursday announced the quick ramp-up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million.

Have a look at the video to know more